Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Angiogenesis
Published in: Angiogenesis 2/2004

01-06-2004

Withaferin A is a potent inhibitor of angiogenesis

Authors: Royce Mohan, Hans Hammers, Paola Bargagna-mohan, Xiaoguo Zhan, Christopher Herbstritt, Antonio Ruiz, Li Zhang, Art Hanson, Barry Conner, John Rougas, Victor Pribluda

Published in: Angiogenesis | Issue 2/2004

Login to get access
Metadata
Title
Withaferin A is a potent inhibitor of angiogenesis
Authors
Royce Mohan
Hans Hammers
Paola Bargagna-mohan
Xiaoguo Zhan
Christopher Herbstritt
Antonio Ruiz
Li Zhang
Art Hanson
Barry Conner
John Rougas
Victor Pribluda
Publication date
01-06-2004
Publisher
Kluwer Academic Publishers
Published in
Angiogenesis / Issue 2/2004
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-004-1026-3

Other articles of this Issue 2/2004

Angiogenesis 2/2004 Go to the issue

OriginalPaper

Vascular Targeting Agents: Therapeutics and Diagnostic Development

OriginalPaper

In vivo videomicroscopy reveals differential effects of the vascular-targeting agent ZD6126 and the anti-angiogenic agent ZD6474 on vascular function in a liver metastasis model

OriginalPaper

Abstracts of the 15th Endothelial Cell Research Symposium Maastricht Auditorium, Maastricht, The Netherlands 23 November 2004

OriginalPaper

Inhibition of FGF receptor activity in glioma implanted into the mouse brain using the tetracyclin-regulated expression system

OriginalPaper

Protamine enhances uptake of cationic liposomes in angiogenic microvessels of solid tumours

OriginalPaper

Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2) fail to inhibit endothelial cell proliferation or formation of microvessels from rat aortic rings in vitro

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits